Enanta-JPM-20240110.pdf

1、Corporate PresentationJanuary 10,2024 2024 Enanta Pharmaceuticals,Inc.|This presentation contains forward-looking statements concerning our business,operations and financial performance andcondition,as well as our plans,objectives and expectations for our research and development programs,our busine

2、ss and theindustry in which we operate.Any statements contained herein that are not statements of historical facts may be deemed to beforward-looking statements.In some cases,you can identify forward-looking statements by terminology such as“aim,”“anticipate,”“assume,”“believe,”“contemplate,”“contin

3、ue,”“could,”“due,”“estimate,”“expect,”“goal,”“intend,”“may,”“objective,”“plan,”“predict,”“potential,”“positioned,”“seek,”“should,”“target,”“will,”“would,”and other similar expressions that are predictions of orindicate future events and future trends,as well as other comparable terminology.These for

4、ward-looking statements include,but arenot limited to,statements about overall trends,royalty revenue trends,research and clinical development plans and prospects,liquidity and capital needs and other statements of expectations,beliefs,future plans and strategies,anticipated events or trends,and sim

5、ilar expressions.These forward-looking statements are based on our managements current expectations,estimates,forecasts and projections about our business and the industry in which we operate and our managements beliefs and assumptions.These forward-looking statements are not guarantees of future pe

6、rformance or results and involve known and unknown risks,uncertainties and other factors that are in some cases beyond our control.As a result,any or all of our forward-looking statementsin this presentation may turn out to be inaccurate.Please refer to the risk factors described or referred to in“R